Bosentan

Tracleer

View Post: Bosentan Improves Cardiovascular Parameters in Patients With ...
18 Nov 2009 by admin
In patients with moderate to severe chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH), bosentan plus best conventional care produced greater improvement in cardiovascular parameters than best conventional care ...
View Blog: genglob magazine - http://www.genglob.com/genglobmag/

View Post: Acute Hemodynamic Effects of Single-Dose Sildenafil When Added to ...
20 Oct 2009 by Gruenig, E., Michelakis, E., Vachiery,...
This study investigated the acute pharmacodynamic effects of sildenafil in patients with pulmonary arterial hypertension (PAH) and concomitant bosentan treatment, in view of a mutual pharmacokinetic interaction between the 2 drugs. ...
View Blog: The Journal of Clinical Pharmacology current issue - http://jcp.sagepub.com/

View Post: Clinical and Hemodynamic Effects of Bosentan Dose Optimization in ...
29 Oct 2007
Clinical and Hemodynamic Effects of Bosentan Dose Optimization in Symptomatic Heart Failure Patients with Severe Systolic Dysfunction, Associated with Secondary Pulmonary Hypertension - A Multi-Center Randomized Study ...
View Blog: American Journal of Nephrology : Last 20 articles - http://content.karger.com/

View Post: Actelion Provides Update On BUILD-3 Study In Idiopathic Pulmonary ...
19 Nov 2009 by admin
Actelion Ltd (SIX: ATLN) announced that the Independent Data and Safety Monitoring Board (DSMB) has recommended continuation of the pivotal Phase III study BUILD-3, evaluating the efficacy and safety of bosentan (Tracleer�) in patients ...
View Blog: Discuss Pharmacy - http://discusspharmacy.com/

View Post: An atypical presentation of liver enzyme elevation resulting from ...
25 Oct 2009 by Mulchey-K, Bshouty-Z.
Hepatocellular enzyme elevation is a known side effect of both bosentan and atorvastatin. However, a rise in liver enzyme level not characteristic of either agent individually may represent a reaction to their combination or an atypical ...
View Blog: ATORVASTATIN - http://dstools.dialog.com/edds/rss/

View Post: Sildenafil (Viagra) intravenous injection (IV) Revatio gets US FDA ...
27 Nov 2009 by pillscribe
If patients are taking Revatio with bosentan or medicines like barbiturates, carbamazepine, phenytoin, efavirenz, nevirapine, rifampin or rifabutin, their doctor may adjust their dose. Taking vitamin K antagonists (like Coumadin or ...
View Blog: DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/

View Post: Bosentan for pulmonary hypertension and other pulmonary diseases ...
22 Oct 2009 by medicus viennensis
Bosentan is a dual endothelin-receptor antagonist that initially received approval for treatment of WHO group I pulmonary arterial hypertension (PAH) for patients in functional classes III and IV. Analysis of a study conducted in ...
View Blog: Neuigkeiten aus der Welt der Medizin - http://denistodorut.blogspot.com/

View Post: tracleer (bosentan) receives new indication in patients with ...
11 Jul 2009 by prolifebooster
actelion pharmaceuticals uk ltd announced that tracleer� (bosentan), a dual endothelin receptor antagonist, has been approved in the uk and ireland owing the reduction of the army of further digital ulcers (dus) in patients with ...
View Blog: prolifebooster - http://prolifebooster.modelsorg.com/

View Post: FDA Approves Intravenous Formulation Of Pfizer's Revatio ...
20 Nov 2009
The efficacy of Revatio has not been adequately evaluated in patients taking bosentan concurrently. Revatio Injection is for the continued treatment of patients with pulmonary arterial hypertension who are currently prescribed Revatio ...
View Blog: Latest articles from PMD - http://www.pmdcentral.com/